Apr 22, 2024 05:47AM

Dec 19, 2023 11:13AM

Jan 9, 2023 05:05AM

Jan 8, 2023 03:00PM

Jan 8, 2023 03:00PM

Jan 5, 2023 07:00AM

Jan 5, 2023 07:00AM Amryt Announces Positive Top Line Results from Phase 3 Pediatric Trial of Lomitapide in HoFH

Dec 19, 2022 07:02AM

Dec 19, 2022 07:00AM

Dec 19, 2022 07:00AM

Dec 5, 2022 07:00AM

Dec 5, 2022 07:00AM

Nov 30, 2022 07:00AM

Nov 30, 2022 07:00AM Amryt Announces New Patent for Mycapssa®

Nov 3, 2022 07:00AM

Nov 3, 2022 07:00AM

Oct 25, 2022 07:00AM

Oct 25, 2022 07:00AM

Oct 25, 2022 07:00AM

Oct 24, 2022 07:00AM

Oct 19, 2022 07:00AM Amryt to Report Q3 2022 Results on November 3, 2022

Oct 18, 2022 07:00AM

Oct 18, 2022 07:00AM

Oct 17, 2022 07:01AM

Oct 17, 2022 07:00AM

Oct 17, 2022 07:00AM

Sep 23, 2022 07:00AM

Sep 16, 2022 07:30AM Amryt (AMYT) Receives Positive CHMP Opinion for Mycapssa

Sep 16, 2022 07:30AM

Sep 16, 2022 07:30AM

Sep 13, 2022 07:04AM

Sep 13, 2022 07:00AM

Sep 13, 2022 07:00AM

Sep 8, 2022 07:00AM

Sep 8, 2022 07:00AM Amryt Receives Marketing Authorisation Approval and Orphan Drug Designation for Filsuvez® in Great Britain

Sep 7, 2022 07:00AM

Sep 7, 2022 07:00AM

Aug 4, 2022 07:00AM

Aug 4, 2022 07:00AM

Jul 21, 2022 07:00AM

Jul 21, 2022 07:00AM

Jul 14, 2022 07:00AM Amryt Receives Orphan Drug Designation from the FDA for Mycapssa® (oral octreotide) for the Treatment of Carcinoid Syndrome

Jul 14, 2022 07:00AM

Jul 7, 2022 07:01AM

Jul 7, 2022 07:00AM

Jul 7, 2022 07:00AM

Jul 1, 2022 07:00AM

Jul 1, 2022 07:00AM

Jun 27, 2022 07:00AM Amryt Announces Appointment of Dr Tracy Cunningham as Chief Medical Officer

Jun 27, 2022 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All